Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Radiopharmaceuticals in Nuclear Medicine Supply, Demand and Key Producers, 2024-2030

date 13 Sep 2024

date Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

USD4480.00

Add To Cart

Add To Cart

Global Radiopharmaceuticals in Nuclear Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Sep 2024

date Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

USD3480.00

Add To Cart

Add To Cart

Global Radiopharmaceuticals in Nuclear Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 03 Aug 2023

date Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

According to our (Global Info Research) latest study, the global Radiopharmaceuticals in Nuclear Medicine market size was valued at USD 4943.7 million in 2022 and is forecast to a readjusted size of USD 6857.2 million by 2029 with a CAGR of 4.8% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Radiopharmaceuticals in Nuclear Medicine Supply, Demand and Key Producers, 2023-2029

date 03 Aug 2023

date Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

The global Radiopharmaceuticals in Nuclear Medicine market size is expected to reach $ 6857.2 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 13 Sep 2024

industry Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

USD4480.00

addToCart

Add To Cart

industry 13 Sep 2024

industry Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

USD3480.00

addToCart

Add To Cart

industry 03 Aug 2023

industry Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

According to our (Global Info Research) latest study, the global Radiopharmaceuticals in Nuclear Medicine market size was valued at USD 4943.7 million in 2022 and is forecast to a readjusted size of USD 6857.2 million by 2029 with a CAGR of 4.8% during review period.

USD3480.00

addToCart

Add To Cart

industry 03 Aug 2023

industry Pharma & Healthcare

new_biaoQian Radiopharmaceuticals in Nuclear Medicine

The global Radiopharmaceuticals in Nuclear Medicine market size is expected to reach $ 6857.2 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart